Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer

By Aurilio Gaetano   Monfardini Lorenzo   Rizzo Stefania   Sciandivasci Angela   Preda Lorenzo   Bagnardi Vincenzo   Disalvatore Davide   Pruneri Giancarlo   Munzone Elisabetta   Della Vigna Paolo   Renne Giuseppe   Bellomi Massimo   Curigliano Giuseppe   Goldhirsch Aron   Nolè Franco  

Acta Oncologica, Vol. 52, Iss. 8, 2013-11 ,pp. : 1649-1656

Informa Healthcare

Access to resources Recommend Favorite

Dual human epidermal growth factor receptor 2 blockade for the treatment of HER2-positive breast cancer

By Alvarez Ricardo  

Breast Cancer, Vol. 20, Iss. 2, 2013-04 ,pp. : 103-110

Springer Publishing Company

Access to resources Recommend Favorite

Adding hormonal therapy to chemotherapy and trastuzumab improves prognosis in patients with hormone receptor-positive and human epidermal growth factor receptor 2-positive primary breast cancer

By Hayashi Naoki  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 523-531

Springer Publishing Company

Access to resources Recommend Favorite

Epidermal growth factor receptor gene mutation status and its association with clinical characteristics and tumor markers in nonsmallcell lung cancer patients in Northwest China

By            

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 847-850

Science Publishers

Access to resources Recommend Favorite

Anthocyanins potentiate the activity of trastuzumab in human epidermal growth factor receptor 2positive breast cancer cells in vitro and in vivo

By              

Molecular Medicine Reports, Vol. 10, Iss. 4, 2014-01 ,pp. : 1921-1926

Spandidos Publications

Access to resources Recommend Favorite